These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10220955)
1. [New ways in aerosol therapy. Development of FCKW-free gases-- powder inhalation systems]. Haidl GP Fortschr Med; 1999 Mar; 117(8):34-6, 38-9. PubMed ID: 10220955 [TBL] [Abstract][Full Text] [Related]
2. Switching to CFC-free beclometasone for asthma. Drug Ther Bull; 2008 Jun; 46(6):46-8. PubMed ID: 18525059 [TBL] [Abstract][Full Text] [Related]
3. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Laube BL Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400 [TBL] [Abstract][Full Text] [Related]
4. Inhalation therapy of the future--how will it change the way we treat asthma? Lötvall J J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893 [TBL] [Abstract][Full Text] [Related]
6. The CFC to HFA transition and its impact on pulmonary drug development. Leach CL Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403 [TBL] [Abstract][Full Text] [Related]
7. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Geller DE Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367 [TBL] [Abstract][Full Text] [Related]
8. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Geller DE Respir Care; 2002 Dec; 47(12):1392-404; discussion 1404-5. PubMed ID: 12467498 [TBL] [Abstract][Full Text] [Related]
9. Inhalatory therapy training: a priority challenge for the physician. Melani AS Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086 [TBL] [Abstract][Full Text] [Related]
11. Paediatric pulmonary drug delivery: considerations in asthma treatment. Berger WE Expert Opin Drug Deliv; 2005 Nov; 2(6):965-80. PubMed ID: 16296802 [TBL] [Abstract][Full Text] [Related]
12. Could interchangeable use of dry powder inhalers affect patients? Price D; Summers M; Zanen P Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996 [TBL] [Abstract][Full Text] [Related]
13. What is new in asthma: new dry powder inhalers. Hannemann LA J Pediatr Health Care; 1999; 13(4):159-65. PubMed ID: 10690079 [TBL] [Abstract][Full Text] [Related]
14. Are outcomes the same with all dry powder inhalers? Thomas M; Williams AE Int J Clin Pract Suppl; 2005 Dec; (149):33-5. PubMed ID: 16280002 [TBL] [Abstract][Full Text] [Related]
15. [Powder inhalation systems]. Kohlhäufl M; Haidl P; Voshaar T; Häussinger K; Köhler D Dtsch Med Wochenschr; 2004 Sep; 129(39):2048-52. PubMed ID: 15386209 [TBL] [Abstract][Full Text] [Related]
16. Novolizer: the new technology for the management of asthma therapy. Köhler D Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537 [TBL] [Abstract][Full Text] [Related]
17. Managing the transition to CFC-free inhalers. Fehrenbach C Prof Nurse; 2000 Jan; 15(4):248-50. PubMed ID: 10983140 [TBL] [Abstract][Full Text] [Related]
18. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy. Onoue S; Misaka S; Kawabata Y; Yamada S Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334 [TBL] [Abstract][Full Text] [Related]
19. A review of the development of Respimat Soft Mist Inhaler. Dalby R; Spallek M; Voshaar T Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496 [TBL] [Abstract][Full Text] [Related]
20. Guidelines for devices and choices. Everard ML J Aerosol Med; 2001; 14 Suppl 1():S59-64. PubMed ID: 11424895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]